HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Broad neutralization of H1 and H3 viruses by adjuvanted influenza HA stem vaccines in nonhuman primates.

Abstract
Seasonal influenza vaccines confer protection against specific viral strains but have restricted breadth that limits their protective efficacy. The H1 and H3 subtypes of influenza A virus cause most of the seasonal epidemics observed in humans and are the major drivers of influenza A virus-associated mortality. The consequences of pandemic spread of COVID-19 underscore the public health importance of prospective vaccine development. Here, we show that headless hemagglutinin (HA) stabilized-stem immunogens presented on ferritin nanoparticles elicit broadly neutralizing antibody (bnAb) responses to diverse H1 and H3 viruses in nonhuman primates (NHPs) when delivered with a squalene-based oil-in-water emulsion adjuvant, AF03. The neutralization potency and breadth of antibodies isolated from NHPs were comparable to human bnAbs and extended to mismatched heterosubtypic influenza viruses. Although NHPs lack the immunoglobulin germline VH1-69 residues associated with the most prevalent human stem-directed bnAbs, other gene families compensated to generate bnAbs. Isolation and structural analyses of vaccine-induced bnAbs revealed extensive interaction with the fusion peptide on the HA stem, which is essential for viral entry. Antibodies elicited by these headless HA stabilized-stem vaccines neutralized diverse H1 and H3 influenza viruses and shared a mode of recognition analogous to human bnAbs, suggesting that these vaccines have the potential to confer broadly protective immunity against diverse viruses responsible for seasonal and pandemic influenza infections in humans.
AuthorsNicole Darricarrère, Yu Qiu, Masaru Kanekiyo, Adrian Creanga, Rebecca A Gillespie, Syed M Moin, Jacqueline Saleh, Jose Sancho, Te-Hui Chou, Yanfeng Zhou, Ruijun Zhang, Shujia Dai, Anthony Moody, Kevin O Saunders, Michelle C Crank, John R Mascola, Barney S Graham, Chih-Jen Wei, Gary J Nabel
JournalScience translational medicine (Sci Transl Med) Vol. 13 Issue 583 (03 03 2021) ISSN: 1946-6242 [Electronic] United States
PMID33658355 (Publication Type: Journal Article, Research Support, N.I.H., Intramural, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2021 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works.
Chemical References
  • Antibodies, Viral
  • Antigen-Antibody Complex
  • Broadly Neutralizing Antibodies
  • Hemagglutinin Glycoproteins, Influenza Virus
  • Influenza Vaccines
  • Ferritins
Topics
  • Animals
  • Antibodies, Viral (biosynthesis, chemistry)
  • Antigen-Antibody Complex (chemistry)
  • Broadly Neutralizing Antibodies (biosynthesis, chemistry)
  • COVID-19
  • Ferritins (chemistry, immunology)
  • Hemagglutinin Glycoproteins, Influenza Virus (chemistry, genetics, immunology)
  • Humans
  • Influenza Vaccines (administration & dosage, chemistry, immunology)
  • Influenza, Human (immunology, virology)
  • Macaca fascicularis
  • Models, Molecular
  • Nanoparticles (chemistry)
  • Pandemics
  • Primates (immunology, virology)
  • Protein Structure, Quaternary
  • SARS-CoV-2
  • Translational Research, Biomedical

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: